Detalles de la búsqueda
1.
Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project.
Int J Cancer
; 149(1): 66-74, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634882
2.
Long-term exposure to air pollution and liver cancer incidence in six European cohorts.
Int J Cancer
; 149(11): 1887-1897, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278567
3.
Long-term exposure to fine particle elemental components and lung cancer incidence in the ELAPSE pooled cohort.
Environ Res
; 193: 110568, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33278469
4.
Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals.
Int J Cancer
; 146(1): 58-67, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815851
5.
Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
Int J Cancer
; 143(12): 3071-3082, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29756343
6.
Air pollution and incidence of cancers of the stomach and the upper aerodigestive tract in the European Study of Cohorts for Air Pollution Effects (ESCAPE).
Int J Cancer
; 143(7): 1632-1643, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29696642
7.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(10): 1825-1839, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862437
8.
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(9): 1745, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934835
9.
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Support Care Cancer
; 26(4): 1345-1352, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29168033
10.
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol
; 178(1): 61-71, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28382618
11.
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Haematologica
; 102(8): 1361-1367, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522574
12.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212292
13.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Int J Mol Sci
; 18(4)2017 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28420120
14.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Mult Scler
; 21(7): 885-93, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25392325
15.
Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease.
Am J Hematol
; 90(1): E17-21, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345590
16.
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol
; 93(3): 459-62, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24441915
17.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951123
18.
Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients.
Am J Hematol
; 89(3): 295-301, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24265174
19.
Anti-Laminin-332-Schleimhautpemphigoid mit laryngealer Beteiligung - adjuvante Behandlung mit Immunadsorption und Rituximab.
J Dtsch Dermatol Ges
; 16(7): 897-900, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29989373
20.
Anti-laminin 332 mucous membrane pemphigoid with laryngeal involvement - adjuvant treatment with immunoadsorption and rituximab.
J Dtsch Dermatol Ges
; 16(7): 897-900, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29927519